Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
De fundamentele vragen die zorgtechnologie oproept
okt 2023
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen
aug 2021 | Hoofdpijn